Search research articles
Contact Us
Filters
Showing results (361-370 of 371) with videos related to
Page
of 38
Sort By:
The Lancet. Diabetes & Endocrinology
|
June 2, 2015
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
Kunihiro Matsushita, Josef Coresh, Yingying Sang, et al.
Journal of the Endocrine Society
|
April 27, 2018
Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial
Aneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Journal of the American Society of Nephrology : JASN
|
December 15, 2015
Past Decline Versus Current eGFR and Subsequent Mortality Risk
David M J Naimark, Morgan E Grams, Kunihiro Matsushita, et al.
BMJ Open
|
October 11, 2020
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative
Derralynn A Hughes, Patricio Aguiar, Patrick B Deegan, et al.
Journal of Medical Genetics
|
November 8, 2023
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study
Eric L Wallace, Ozlem Goker-Alpan, William R Wilcox, et al.
European Heart Journal
|
April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints
Patrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 24, 2012
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials
Mark D Okusa, Bruce A Molitoris, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 24, 2012
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings
Bruce A Molitoris, Mark D Okusa, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 24, 2012
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology
Paul M Palevsky, Bruce A Molitoris, Mark D Okusa, et al.
Journal of the American Society of Nephrology : JASN
|
April 15, 2017
Global Cardiovascular and Renal Outcomes of Reduced GFR
Bernadette Thomas, Kunihiro Matsushita, Kalkidan Hassen Abate, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 371) with videos related to
Sort By:
Page
of 38
The Lancet. Diabetes & Endocrinology
|
June 2, 2015
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
Kunihiro Matsushita, Josef Coresh, Yingying Sang, et al.
Journal of the Endocrine Society
|
April 27, 2018
Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial
Aneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
Journal of the American Society of Nephrology : JASN
|
December 15, 2015
Past Decline Versus Current eGFR and Subsequent Mortality Risk
David M J Naimark, Morgan E Grams, Kunihiro Matsushita, et al.
BMJ Open
|
October 11, 2020
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative
Derralynn A Hughes, Patricio Aguiar, Patrick B Deegan, et al.
Journal of Medical Genetics
|
November 8, 2023
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study
Eric L Wallace, Ozlem Goker-Alpan, William R Wilcox, et al.
European Heart Journal
|
April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints
Patrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 24, 2012
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials
Mark D Okusa, Bruce A Molitoris, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 24, 2012
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings
Bruce A Molitoris, Mark D Okusa, Paul M Palevsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
March 24, 2012
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology
Paul M Palevsky, Bruce A Molitoris, Mark D Okusa, et al.
Journal of the American Society of Nephrology : JASN
|
April 15, 2017
Global Cardiovascular and Renal Outcomes of Reduced GFR
Bernadette Thomas, Kunihiro Matsushita, Kalkidan Hassen Abate, et al.
Page
of 38